Transcend Medical, Inc.

Alcon, Inc.

Novartis Ag

Dan Rosenman

Eugene De Juan, Jr

Stephen A Boyd

Hanson S Gifford, Iii

Mark E Deem

Eugene De Juan

Tom Silvestrini

Stephen Boyd

Iii Gifford Hanson S

Hanson S Gifford Iii

Hanson S Iii Gifford

Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.

Glaucoma treatment device

An ocular implant includes an elongate member having an internal lumen forming a flow pathway that provides a fluid pathway between the anterior chamber and the suprachoroidal space of the eye. The implant includes a hydrogel member attached to the elongate member, wherein the hydrogel member is adapted to expand upon implantation of the elongate member in the eye. An attachment attaches the hydrogel member to the elongate member.

Ocular implant with hydrogel expansion capabilities

Growing community of inventors

San Francisco, CA, United States of America

Dan Rosenman